company

MEDKOS AS

8430 MYRE

Return on Equity
65,77 %
Current Ratio
0,29
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue106 000
Net Income−146 000
Total Assets90 000
Total Equity−222 000
Income (NOK)2022
Revenue106 000
Expenditure251 000
Operating Profit−145 000
Financial Income0
Financial Costs1 000
Financial Balance−1 000
Earnings Before Tax−146 000
Tax0
Net Income−146 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets90 000
Total Assets90 000
Total Retained Equity−252 000
Total Equity−222 000
Total Long-Term Debt0
Total Current Debt313 000
Total Equity and Debt90 000
Cash flow (NOK)2022
Sales Income106 000
Other Income0
Revenue106 000
Cost of Goods Sold28 000
Salary Costs0
Depreciation0
Impairment0
Expenditure251 000
Operating Profit−145 000
Financial Income0
Financial Costs1 000
Financial Balance−1 000
Dividends0
Net Income−146 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank32 000
Total Current Assets90 000
Total Assets90 000
Total Equity−222 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors92 000
Unpaid Taxes0
Dividends0
Other Current Debt221 000
Total Current Debt313 000
Total Equity and Debt90 000
Financial indicators2022
Return on Equity65,77 %
Debt-to-Equity Ratio−0
Operating Profit Margin−136,79 %
Current Ratio0,29
Quick Ratio0,29
Equity Ratio−2,47
Gross Profit Margin73,58 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English